WASHINGTON, Dec. 3, 2013 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for the treatment of central nervous system disorders,
today announced that it will deliver a corporate presentation at
the 25th Annual Piper Jaffray Healthcare Conference in
New York City on Wednesday, December 4, 2013 at 11:30 a.m. Eastern Time.
The presentation at the Piper Jaffray Healthcare Conference will
be available live on Vanda's corporate website, where it also will
be archived for 30 days. To access the presentation, go to
Vanda's website at www.vandapharma.com and click on the
Presentations tab on the Investor Relations page. Please
connect to the website several minutes prior to the start of the
live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
the treatment of central nervous system disorders. For more on
Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Chad
Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com
SOURCE Vanda Pharmaceuticals Inc.